Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 16 points (-0.1%) at 16,836 as of Monday, June 30, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,605 issues advancing vs. 1,347 declining with 197 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is unchanged. On the negative front, top decliners within the industry include Accelerate Diagnostics ( AXDX), down 16.7%, ResMed ( RMD), down 4.0%, Edwards Lifesciences ( EW), down 1.7%, Fresenius Medical Care AG & Co. KGaA ( FMS), down 1.2% and Varian Medical Systems ( VAR), down 1.0%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Becton Dickinson ( BDX) is one of the companies pushing the Health Services industry lower today. As of noon trading, Becton Dickinson is down $1.02 (-0.8%) to $118.58 on light volume. Thus far, 253,784 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 779,100 shares. The stock has ranged in price between $118.07-$119.89 after having opened the day at $119.58 as compared to the previous trading day's close of $119.60.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. Becton Dickinson has a market cap of $23.1 billion and is part of the health care sector. Shares are up 8.2% year-to-date as of the close of trading on Friday. Currently there are 6 analysts that rate Becton Dickinson a buy, 2 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, expanding profit margins, good cash flow from operations and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Becton Dickinson Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, CR Bard ( BCR) is down $0.98 (-0.7%) to $143.25 on average volume. Thus far, 387,522 shares of CR Bard exchanged hands as compared to its average daily volume of 890,300 shares. The stock has ranged in price between $142.87-$144.50 after having opened the day at $144.40 as compared to the previous trading day's close of $144.23.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. CR Bard has a market cap of $11.0 billion and is part of the health care sector. Shares are up 7.7% year-to-date as of the close of trading on Friday. Currently there are 2 analysts that rate CR Bard a buy, 1 analyst rates it a sell, and 11 rate it a hold.

TheStreet Ratings rates CR Bard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, expanding profit margins and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CR Bard Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Intuitive Surgical ( ISRG) is down $8.25 (-1.9%) to $415.15 on light volume. Thus far, 245,339 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 664,000 shares. The stock has ranged in price between $412.02-$422.17 after having opened the day at $421.78 as compared to the previous trading day's close of $423.40.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $15.8 billion and is part of the health care sector. Shares are up 10.2% year-to-date as of the close of trading on Friday. Currently there are 8 analysts that rate Intuitive Surgical a buy, 3 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Intuitive Surgical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null